Enveda: $150 Million Series D Raised To Advance Clinical Trials And Enhance Leadership

Retrieved on: 2025-09-11 15:17:29

Tags for this article:

Drug discovery

Clinical research

Drug development

Pfizer

Investigational New Drug

Metabolomics

Click the tags to see associated articles and topics

Enveda: $150 Million Series D Raised To Advance Clinical Trials And Enhance Leadership. View article details on hiswai:

Excerpt

... Lux Capital. It follows a previous $150 million Series C round that included support from Sanofi. And this latest investment brings the company's ...

Article found on: pulse2.com

View Original Article